|
1
|
Zou K, Liu C, Zhang Z and Zou L: The
effect of elemene on lung adenocarcinoma A549 cell radiosensitivity
and elucidation of its mechanism. Clinics (Sao Paulo). 70:556–562.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mu L, Wang T, Chen Y, Tang X, Yuan Y and
Zhao Y: β-elemene enhances the efficacy of gefitinib on
glioblastoma multiforme cells through the inhibition of the EGFR
signaling pathway. Int J Oncol. 49:1427–1436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi F, Yang G, Ren J, Guo T, Du Y and Feng
N: Formulation design, preparation, and in vitro and in vivo
characterizations of β-elemene-loaded nanostructured lipid
carriers. Int J Nanomedicine. 8:2533–2541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang G, Li X, Huang F, Zhao J, Ding H,
Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect
of β-elemene in non-small-cell lung cancer cells is mediated via
induction of cell cycle arrest and apoptotic cell death. Cell Mol
Life Sci. 62:881–893. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gan Z, Han K, Lin S, Hu H, Shen Z and Min
D: Knockdown of ubiquitin-specific peptidase 39 inhibited the
growth of osteosarcoma cells and induced apoptosis in vitro. Biol
Res. 50:152017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen W, Lu Y, Wu J, Gao M, Wang A and Xu
B: Beta-elemene inhibits melanoma growth and metastasis via
suppressing vascular endothelial growth factor-mediated
angiogenesis. Cancer Chemother Pharmacol. 67:799–808. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tao L, Zhou L, Zheng L and Yao M: Elemene
displays anti-cancer ability on laryngeal cancer cells in vitro and
in vivo. Cancer Chemother Pharmacol. 58:24–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zengyong Q, Jiangwei M and Huajin L:
Effect of Ligusticum wallichii aqueous extract on oxidative injury
and immunity activity in myocardial ischemic reperfusion rats. Int
J Mol Sci. 12:1991–2006. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao Y, Liu Y and Chen K: Mechanisms and
clinical application of tetramethylpyrazine (an interesting natural
compound isolated from Ligusticum wallichii): Current status and
perspective. Oxid Med Cell Longev. 2016:21246382016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu J, Lang Y, Cao Y, Zhang T and Lu H: The
neuroprotective effect of tetramethylpyrazine against contusive
spinal cord injury by activating PGC-1α in rats. Neurochem Res.
40:1393–1401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu X, Liu H, Zeng Z, Zhou W, Liu J and He
Z: Pharmacokinetics of ligustrazine ethosome patch in rats and
anti-myocardial ischemia and anti-ischemic reperfusion injury
effect. Int J Nanomedicine. 6:1391–1398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou Y and Nathans J: Gpr124 controls CNS
angiogenesis and blood-brain barrier integrity by promoting
ligand-specific canonical wnt signaling. Dev Cell. 31:248–256.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu XZ, Liu LF, Zhou XJ, Xiao S, Long JW
and Zhou X: GPR124 expression and its relationship with prognosis
in hepatocellular carcinoma. Cancer Res Prev Treat. 41:1082–1086.
2014.
|
|
14
|
Li P, Zhou X, Sun W, Sheng W, Tu Y, Yu Y,
Dong J, Ye B, Zheng Z and Lu M: Elemene induces apoptosis of human
gastric cancer cell line BGC-823 via extracellular signal-regulated
kinase (ERK) 1/2 signaling pathway. Med Sci Monit. 23:809–817.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu J, Liu X, Qiu G, Zhang Z, Fan L, Zhao
W, He S, Chang S and Che X: Effects of β-elemene on proliferation
and apoptosis of SGC7901 gastric cancer cells in vitro and the
underlying mechanisms. Nan Fang Yi Ke Da Xue Xue Bao. 35:1234–1238.
2015.(In Chinese). PubMed/NCBI
|
|
16
|
Cai DY, Gao X, Wu XH and Hong TT:
Synergistic effect of beta-elemene injection combined paclitaxel
injection on human breast cancer MB-468 cells: An in vitro study.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 33:978–982. 2013.(In Chinese).
PubMed/NCBI
|
|
17
|
Zhao X, Kim SY and Park KY: Bamboo salt
has in vitro anticancer activity in HCT-116 cells and exerts
anti-metastatic effects in vivo. J Med Food. 16:9–19. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao X, Wang Q, Li GJ, Chen F, Qian Y and
Wang R: In vitro antioxidant, anti-mutagenic, anti-cancer and
anti-angiogenic effects of Chinese Bowl tea. J Funct Food.
7:590–598. 2014. View Article : Google Scholar
|
|
19
|
Liu WF, Guo W, Niu XH, Yuan RY, Zhang Q,
Xu HR and Chen DF: The establishment of a model of human
osteosarcoma OS-732 xenograft in nude mice. Chin J Bone Tumor Bone
Disease. 7:204–207. 2008.
|
|
20
|
Abdelraouf A, Hamdy H, El Erian AM,
Elsebae M, Taha S, Elshafey HE, Ismail S and Hassany M: Initial
experience of surgical microwave tissue precoagulation in liver
resection for hepatocellular carcinoma in cirrhotic liver. J Egypt
Soc Parasitol. 44:343–350. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Qiu W, Liang J, Yu Z and Yue L:
Anti-tumor effects of pEgr-1-endostatin-TNF-α recombinant plasmid
expression induced by ionizing radiation. Asian Pac J Cancer Prev.
12:2933–2937. 2011.PubMed/NCBI
|
|
22
|
Kan Z, Phongkitkarun S, Kobayashi S, Tang
Y, Ellis LM, Lee TY and Charnsangavej C: Functional CT for
quantifying tumor perfusion in antiangiogenic therapy in a rat
model. Radiology. 237:151–158. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carlson J, Alobuia W and Mizell J: Rectal
gastrointestinal stromal tumor with metastasis to the penis: Case
report and review of literature. Int J Surg Case Rep. 29:172–175.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Cho SG, Wu X, Siwko S and Liu M:
G-protein coupled receptor 124 (GPR124) in endothelial cells
regulates vascular endothelial growth factor (VEGF)-induced tumor
angiogenesis. Curr Mol Med. 14:543–554. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Posokhova E, Shukla A, Seaman S, Volate S,
Hilton MB, Wu B, Morris H, Swing DA, Zhou M, Zudaire E, et al:
GPR124 functions as a WNT7-specific coactivator of canonical
β-catenin signaling. Cell Rep. 10:123–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma R, Yuan B, Du J, Wang L, Ma L, Liu S,
Shu Q and Sun H: Electroacupuncture alleviates nerve injury after
cerebra ischemia in rats through inhibiting cell apoptosis and
changing the balance of MMP-9/TIMP-1 expression. Neurosci Lett.
633:158–164. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vafadari B, Salamian A and Kaczmarek L:
MMP-9 in translation: From molecule to brain physiology, pathology,
and therapy. J Neurochem. 139 Suppl 2:S91–S114. 2016. View Article : Google Scholar
|
|
28
|
Breynaert C, de Bruyn M, Arijs I, Cremer
J, Martens E, Van Lommel L, Geboes K, De Hertogh G, Schuit F,
Ferrante M, et al: Genetic deletion of tissue inhibitor of
metalloproteinase-1/TIMP-1 alters inflammation and attenuates
fibrosis in dextran sodium sulphate-induced murine models of
colitis. J Crohns Colitis. 10:1336–1350. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu D, Shen Z, Liu J, Chen J, Liu Y, Hu C,
Li Z and Li Y: The ROS-mediated activation of STAT-3/VEGF signaling
is involved in the 27-hydroxycholesterol-induced angiogenesis in
human breast cancer cells. Toxicol Lett. 264:79–86. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong YF, Zhang XM, Liu F, Wang ZZ, Deng
XF, Jiao Y, Li XJ and Huang XY: Inhibitory effect of recombinant
human endostatin on the proliferation of hypertrophic scar
fibroblasts in a rabbit ear model. Eur J Pharmacol. 791:647–654.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang L, Zhang J, Chen Z, Wang L, Wu X and
Ou M: Epidermal growth factor (EGF) triggers the malignancy of
hemangioma cells via activation of NF-κB signals. Biomed
Pharmacother. 82:133–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qiu X, Guo S, Wu H, Chen J and Zhou Q:
Identification of Wnt pathway, uPA, PAI-1, MT1-MMP, S100A4 and
CXCR4 associated with enhanced metastasis of human large cell lung
cancer by DNA microarray. Minerva Med. 103:151–164. 2012.PubMed/NCBI
|
|
33
|
Nicholson DW and Thorberry NA: Caspase:
Killer proteases. Thernds Bichem Sci. 22:299–306. 1997. View Article : Google Scholar
|
|
34
|
Evdokiou A, Bouralexis S, Atkins GJ, Chai
F, Hay S, Clayer M and Findlay DM: Chemotherapeutic agents
sensitize osteogenic sarcoma cells, but not normal human bone
cells, to Apo2L/TRAIL-induced apoptosis. Int J Cancer. 99:491–504.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xie X, Zhao X, Liu Y, Zhang J, Matusik RJ,
Slawin KM and Spencer DM: Adenovirus-mediated tissue-targeted
expression of a caspase-9-based artificial death swith for the
treatment of prostate cancer. Cancer Res. 61:6795–6804.
2001.PubMed/NCBI
|
